At Trimi Health, the most consequential enrollment milestone is not the delivery date. It is the moment a clinician signs the prescription. The published policy permits a full refund before that point, then generally treats the order as final—even if preparation or shipping has not begun. That makes the relationship between checkout, clinical review and prescription approval central to understanding this online weight-management service.
Trimi offers compounded semaglutide and compounded tirzepatide through a service that attributes clinical care to Arora Health and prescription fulfillment to BelieveRx. Its lowest advertised monthly equivalents require annual prepayment, while shorter billing options have different renewal rules. This review examines public documentation consulted October 19, 2026: what a patient pays for, when commitments attach, which refund exceptions exist and what remains unresolved without the full checkout agreement.
At a glance
- Payment precedes clinical approval
- Trimi collects the selected billing period at checkout before provider review; it promises a full refund if treatment is considered inappropriate.Sources: [4]
- Annual prices require annual payment
- Compounded semaglutide is $99 per month equivalent with $1,188 upfront; compounded tirzepatide is $125 per month equivalent with $1,500 upfront. Both represent 12-month commitments.
- Renewal depends on plan length
- Monthly and quarterly plans renew automatically unless renewal is disabled. Six-month and annual plans do not automatically renew.Sources: [6]
- Prescription signing changes refund rights
- The policy allows cancellation with a full refund before a prescription is written, then generally makes the order noncancelable and nonrefundable, subject to published exceptions.Sources: [9]
- Six-month refund has specific conditions
- The no-weight-loss refund requires six continuous months, treatment adherence, recorded starting and six-month weights, and a claim within 30 days of the six-month mark. The stated benefit covers plan fees paid over those six months; the quoted policy does not establish a refund of an entire annual prepayment.Sources: [9]
Checkout starts a commitment before treatment is approved
Trimi says US residents aged 18 or older can complete its assessment, but applying does not guarantee a prescription. Patients select compounded semaglutide or compounded tirzepatide during signup; a licensed clinician then determines whether that choice is appropriate. The questionnaire asks about medical history, current medications and treatment goals, with an advertised completion time of about five to 10 minutes. Selection at checkout is therefore a request for evaluation, not clinical authorization.
The selected billing period is charged before that review. Trimi says a clinician typically reviews a completed assessment within 12–24 hours and may request more information or additional evaluation. If treatment is inappropriate, the company promises a full refund. Separately, its cancellation policy permits a full refund before a clinician writes the prescription. Those are related protections, but neither creates an open-ended opportunity to reconsider after approval.
The practical question is how a patient can identify the order’s current stage and stop it before prescription signing. The consulted documentation does not establish a guaranteed review delay during which cancellation remains available. Our guide to terms worth reading before enrollment explains why checkout authorization, clinical consent and cancellation permission should be read separately. Trimi’s complete terms of service and individual checkout contract were not examined for this review.
Four billing options, not four monthly subscriptions
Trimi publishes four payment periods for each compounded medication. Only the monthly option collects the stated monthly amount each month. The other figures expressed per month are equivalents derived from a larger charge. Prices are in US dollars before discounts, and Trimi says they remain the same across prescribed doses. The documented offer is injectable and includes syringes and alcohol swabs; the selected descriptions do not establish the anatomical injection route or complete formulation.
The annual semaglutide offer is a $1,188 upfront charge for a 12-month commitment, not a $99 recurring monthly payment. Tirzepatide’s annual equivalent similarly requires $1,500 upfront. Patients can instead choose one of the shorter published options. The distinction matters because a smaller displayed monthly equivalent does not mean a smaller initial transaction, and financing, if offered by a payment provider, does not shorten the treatment-plan commitment.
The table separates the displayed equivalent from the collection period. Our explanation of monthly prices versus billing commitments provides additional context. None of these billing terms establishes how much medication arrives in an individual shipment, how many shipments occur or whether a full prepaid term is dispensed at once. Those fulfillment details need separate confirmation rather than being inferred from a three-, six- or 12-month price.
| Billing option | Compounded semaglutide | Compounded tirzepatide |
|---|---|---|
| Monthly | $175 billed monthly | $235 billed monthly |
| Quarterly | $145/month equivalent; $435 every 3 months | $199/month equivalent; $597 every 3 months |
| Six months | $120/month equivalent; $720 upfront | $175/month equivalent; $1,050 upfront |
| Annual | $99/month equivalent; $1,188 upfront; 12-month commitment | $125/month equivalent; $1,500 upfront; 12-month commitment |
Renewal cancellation does not unwind the purchased term
Monthly and quarterly plans automatically renew unless renewal is turned off. Six-month and annual plans are paid upfront and do not automatically renew; continuing requires a provider check-in and confirmation of another plan. Some promotional billing labels use language such as yearly or every six months, but the more explicit treatment and billing explanations distinguish these longer plans from automatically recurring subscriptions.
Turning off renewal stops a future term; it does not refund or prorate the term already purchased. Trimi illustrates this with a prepaid quarterly plan: disabling renewal in month two leaves the current three-month term intact while preventing the next three-month charge. Patients should obtain confirmation that the change has been made. The evidence examined here does not establish a specific advance-notice deadline, so this review cannot supply one.
A later price reduction also does not release an existing commitment. Trimi excludes refunds, partial refunds, credits and retroactive adjustments solely because a cheaper price or new offer appears. Its policy also prevents ending a committed term early with a refund to repurchase at the lower rate. Readers comparing renewal controls can use our guide to cancellation notice and order status, while checking their own checkout terms for the operative procedure.
The refund policy has a hard boundary and narrower exceptions
Once a clinician signs the prescription, Trimi’s policy generally makes the order noncancelable and nonrefundable whether the medication is being compounded, has been compounded or has shipped. Waiting for a tracking number is therefore not a reliable cancellation strategy. However, describing the policy as absolutely prohibiting refunds would also be inaccurate: other provisions address medical ineligibility, billing errors, verified delivery problems and the conditional six-month no-results refund.
That six-month promise is a commercial refund arrangement, not a promise of an individual clinical outcome. The stated benefit refunds “the plan fees you paid over those six months.” The quoted policy does not establish that a successful claim refunds an entire annual prepayment. The policy requires six continuous months on the prescribed plan, taking medication as directed and logging weight in the patient portal. It defines no results as no net weight loss between the recorded starting weight and the six-month weight. Without both records, the policy says the claim cannot be verified or approved.
A request must be made within 30 days of the six-month mark through Trimi’s contact page. Only one claim is allowed per patient, payment returns to the original method and the benefit does not stack with refunds already issued. Trimi advertises decisions in two to four business days, followed by bank posting typically taking five to 10 business days. Our guide to refund guarantees and exclusions explains why approval timing is not the same as money reaching an account.
What the plan includes—and what promotions do not settle
Trimi says every plan includes the prescribed medication, injection supplies, clinician consultation, ongoing care and support, and free overnight shipping once medication is compounded. It states there are no separate enrollment, consultation, membership or shipping fees. Another description includes ongoing dose management and 24/7 messaging. These are meaningful inclusions, although the consulted documentation does not establish a uniform follow-up schedule, mandatory laboratory requirements, laboratory costs or provision of a sharps container.
The service is self-pay and does not bill insurance. Trimi accepts HSA and FSA payments but tells patients to confirm purchase eligibility with their plan administrator. It also offers a letter of medical necessity to support an insurance reimbursement request, without promising coverage or reimbursement. These are different arrangements: accepting a payment card or providing paperwork does not mean an insurer will pay the treatment bill.
A promotional page offers new patients $50 off their first month using code 50OFF. It does not adequately explain application to every prepaid option, stacking rules or expiration, so the standard prices remain the clearest comparison baseline. Existing patients can also earn $50 when a friend uses their referral link and places a first order, with no stated referral cap. Neither promotion changes the documented prescription-stage refund boundary or the commitment attached to a purchased term.
Trimi, the clinician network and the pharmacy have different roles
Trimi identifies itself as founded in May 2024 and headquartered in New York City. It attributes medical evaluations and prescription decisions to Arora Health, describing a network of US-licensed clinicians conducting asynchronous and synchronous consultations. This does not mean every patient receives a scheduled live appointment or sees a physician specifically. The documented standard entry point is the questionnaire, with additional information or evaluation requested when the treating clinician considers it necessary.
The company identifies BelieveRx, formerly VialsRx, as the prescription-filling pharmacy and publishes Texas pharmacy license number 35264. It describes preparation against individual prescriptions by a state-licensed 503A pharmacy. These are provider representations, not independently verified licensing findings. The review did not check current professional licenses, pharmacy permissions in individual states or certifications against external registries; naming the pharmacy is useful disclosure but does not replace those checks.
Treatment pages advertise Arora Health care in all 50 states, excluding Puerto Rico, while some editorial footers say most states and describe availability checks before payment. This inconsistency warrants address-specific confirmation before checkout. Trimi also explicitly says it does not offer retatrutide. For the documented semaglutide and tirzepatide service, patients should establish who handles prescribing questions, fulfillment problems and billing disputes rather than assuming the platform, clinician network and pharmacy are interchangeable.
Shipping promises need to be read alongside reporting deadlines
Free overnight shipping begins after compounding, not immediately after checkout. Trimi describes temperature-controlled packaging, but its total delivery estimates differ: the homepage says typically one to three days from signup, while its guide says two to four days including clinical review and pharmacy preparation. Neither should be treated as a promised arrival date. The documentation also does not establish a uniform shipment frequency or medication quantity per shipment across all billing plans.
For delivery damage, the refund policy asks patients to photograph the damage before opening anything further and email within 24 hours of the delivery scan. After verification, the stated options are a free replacement shipment or refund. Refrigeration concerns are reviewed with the dispensing pharmacy based on confirmed stability concerns rather than cosmetic packaging issues alone. Separately, FDA advises not using an injectable GLP-1 drug that arrives warm or insufficiently refrigerated and contacting the provider or pharmacy.
Support claims also need channel-specific clarification. The homepage advertises 24/7 care-team availability and responses within one hour, while the contact block lists Monday through Friday, 9 a.m.–6 p.m. EST. It provides care@trytrimi.com and (855) 200-2563. The consulted pages do not fully reconcile those hours with the broader messaging promise. For a time-sensitive delivery complaint, keeping the email, photographs and delivery timestamp provides a record of compliance with the published reporting process.
Contract transparency is not evidence of clinical results
Trimi states that its compounded medications are not FDA approved and that cited clinical trials did not test its compounded preparations or establish their safety or effectiveness. FDA approval concerns a specific drug product, not approval of a clinic or pharmacy. Compounded preparations do not undergo FDA premarket review for safety, effectiveness and quality; that absence alone does not establish clinical inequivalence or validate or condemn this particular service.
FDA recommends compounded drugs when an individual’s medical needs cannot be met by an FDA-approved drug, with a prescription and a state-licensed pharmacy. Trimi’s own language similarly limits consideration of compounded treatment to unmet medical needs. The public descriptions examined here do not establish complete preparation ingredients or concentrations. Patients need product-specific clarification from the prescribing clinician and dispensing pharmacy, rather than treating the medication name as a complete description of what will be supplied.
The contract also cannot answer every care question. Trimi includes provider messaging and clinically appropriate treatment reviews, but a consistent check-in calendar is not documented. NIDDK describes follow-up as addressing response and tolerability, not simply continued payment. Before purchasing a longer term, useful unresolved questions include how medical concerns affect continued fulfillment, what happens if treatment changes and which written refund exception would apply. The six-month commercial promise should not substitute for those answers.
Questions & answers
Can I pay Trimi $99 or $125 each month?
Those figures are annual-plan monthly equivalents, not monthly installments. Compounded semaglutide requires $1,188 upfront for that annual offer, and compounded tirzepatide requires $1,500 upfront. Actual monthly billing is separately listed at $175 and $235, respectively. Quarterly and six-month options also exist. Any payment-provider financing has its own terms and does not shorten the treatment commitment.
Can I cancel before my medication ships?
Shipment is not the controlling boundary. Trimi permits cancellation with a full refund before a clinician writes the prescription. After signing, its general policy makes the order final even if compounding or shipping has not occurred. Specific refund exceptions remain available under other provisions. Ask support to confirm prescription status rather than assuming an unshipped order is still cancelable.
Will my six-month or annual Trimi plan renew automatically?
The explicit billing explanation says no. Continuing a six-month or annual plan requires a provider check-in and confirmation of a new plan. Monthly and quarterly plans do automatically renew unless renewal is disabled. Turning off renewal does not refund the current purchased term. Keep confirmation of the change, and verify the applicable renewal procedure in the checkout agreement.
What records are needed for the six-month no-results refund?
The policy requires six continuous months on the prescribed plan, taking medication as directed and portal records of starting weight and weight at six months. No results means no net loss between those logged measurements. The stated benefit refunds plan fees paid over those six months; the quoted policy does not establish that a successful claim refunds an entire annual prepayment. Submit the request within 30 days of the six-month mark. It is limited to one claim per patient and does not stack with refunds already issued.
Does Trimi accept insurance or help with reimbursement?
Trimi describes itself as self-pay and does not bill insurance. It accepts HSA and FSA payments, subject to confirmation with the plan administrator that the purchase qualifies. It can provide a letter of medical necessity for an insurance reimbursement request, but coverage and reimbursement are not guaranteed. These options should not be treated as an assurance that another payer will absorb the charge.
What should I do if a Trimi delivery is damaged or warm?
For damage, Trimi asks for a clear photograph before further opening and an email within 24 hours of the delivery scan; verified claims can receive a replacement or refund. FDA advises not using an injectable GLP-1 drug that arrives warm or inadequately refrigerated and contacting the provider or pharmacy. Trimi says refrigeration-related replacement decisions involve pharmacy review of confirmed stability concerns.
Our assessment
Trimi provides useful detail on billing amounts, included services, renewal differences and refund conditions. That is more informative than an isolated monthly price. The trade-off is a meaningful upfront commitment on longer plans and a restrictive general cancellation boundary at prescription signing, not shipment. Its conditional six-month refund does not erase those restrictions. Before paying, obtain confirmation of the selected charge, renewal status, state availability, shipment schedule and process for treatment-related changes. The delivery estimates and support hours also need clarification. This documentary review cannot establish clinical quality or verify licensing, and the complete checkout contract was not examined. Trimi’s public terms support a concrete comparison of commitments, but not a conclusion that its lowest monthly equivalent is the best fit for every prospective patient.
This opens the reviewed business’s website. The link is not a prescription or endorsement. Commercial relationships.
Sources & documentation
Public materials consulted October 19, 2026. Provider statements are attributed claims, not independently verified clinical outcomes. Terms can change; obtain a current written quote.
- FDA concerns with unapproved GLP-1 drugs used for weight loss ↗
- NIDDK: prescription medications for overweight and obesity ↗
- Trimi / Trimi Health — treatments/semaglutide ↗
- Trimi / Trimi Health — official website ↗
- Trimi / Trimi Health — treatments/tirzepatide ↗
- Trimi / Trimi Health — blog/trimi pricing subscription shipping ↗
- Trimi / Trimi Health — blog/cost affordability hub ↗
- Trimi / Trimi Health — blog/cheapest legal glp1 online 2026 ↗
- Trimi / Trimi Health — refund policy ↗
- Trimi / Trimi Health — promo ↗
- Trimi / Trimi Health — how it works ↗
- Trimi / Trimi Health — cost guide ↗